Ciclesonide modulates in vitro allergen-driven activation of blood mononuclear cells and allergen-specific T-cell blasts

Immunology Letters

Volumn 141, Issue 2, 2012, Pages 190-196

  Silvestri, Michela ^a   Morandi, Fabio ^a   Pistoia, Vito ^a   Prigione, Ignazia ^a   Rossi, Giovanni A ^a  

^a G GASLINI INSTITUTE   (Italy)

Author keywords

Allergen specific T cell blasts; Antigen; Atopy; Corticosteroid; Peripheral blood mononuclear cells

Indexed keywords

ALLERGEN; ANTIGEN; CICLESONIDE; DESISOBUTYRYL CICLESONIDE; INTERLEUKIN 4; RADIOPHARMACEUTICAL AGENT; THYMIDINE H 3; UNCLASSIFIED DRUG;

ADOLESCENT; ALLERGIC ASTHMA; ARTICLE; CANDIDA ALBICANS; CELL CULTURE; CELL ISOLATION; CELL PROLIFERATION; CELL SPECIFICITY; CHILD; CLINICAL ARTICLE; CONCENTRATION RESPONSE; CONTROLLED STUDY; DRUG ACTIVITY; DRUG EFFICACY; FEMALE; HUMAN; IMMUNOMODULATION; IN VITRO STUDY; LEUKOCYTE ACTIVATION; LYMPHOBLAST; LYMPHOCYTE ACTIVATION; MALE; PERIPHERAL BLOOD MONONUCLEAR CELL; PHLEUM PRATENSE; PRIORITY JOURNAL; PROTEIN EXPRESSION; REGULATORY MECHANISM; SCHOOL CHILD; SENSITIZATION;

ALLERGENS; ANTI-ALLERGIC AGENTS; ANTIGENS, PLANT; ASTHMA; CANDIDA ALBICANS; CELL PROLIFERATION; CHILD; FEMALE; FUNGAL PROTEINS; HUMANS; IMMUNIZATION; INTERLEUKIN-4; LEUKOCYTES, MONONUCLEAR; LYMPHOCYTE ACTIVATION; MALE; PHLEUM; PREGNENEDIONES; T-LYMPHOCYTES; UP-REGULATION;

EID: 84855954812     PISSN: 01652478     EISSN: 18790542     Source Type: Journal    
DOI: 10.1016/j.imlet.2011.10.003     Document Type: Article

References (35)

1. Fanta C.H., Asthma N. N Engl J Med 2009, 360:1002-1014.
2. Umland S.P., Schleimer R.P., Johnston S.L. Review of the molecular and cellular mechanisms of action of glucocorticoids for use in asthma. Pulm Pharmacol Ther 2002, 15:35-50.
3. Barnes P.J. How corticosteroids control inflammation: Quintiles Prize Lecture 2005. Br J Pharmacol 2006, 148:245-254.
4. Jeffery P. Anti-inflammatory effects of inhaled corticosteroids in chronic obstructive pulmonary disease: similarities and differences to asthma. Expert Opin Invest Drugs 2005, 14:619-632.
5. Barnes P.J., Adcock I.M. How do corticosteroids work in asthma?. Ann Intern Med 2003, 139:359-370.
6. Chanez P., Bourdin A., Vachier I., Godard P., Bousquet J., Vignola A.M. Effects of inhaled corticosteroids on pathology in asthma and chronic obstructive pulmonary disease. Proc Am Thorac Soc 2004, 1:184-190.
7. Larche M., Robinson D.S., Kay A.B. The role of T lymphocytes in the pathogenesis of asthma. J Allergy Clin Immunol 2003, 111:450-463.
8. Oddera S., Silvestri M., Sacco O., Scarso L., Lantero S., Quaglia R., et al. Effects of " systemic" budesonide concentrations on in vitro allergen-induced activation of blood mononuclear cells isolated from asthmatic patients. Allergy 1995, 50:397-404.
9. Lantero S., Sacco O., Scala C., Spallarossa D., Rossi D.G.A. Eosinophil locomotion and the release of IL-3 and IL-5 by allergen stimulated mononuclear cells are effectively downregulated " in vitro" by budesonide. Clin Exp Allergy 1996, 26:656-664.
10. Powell N., Till S.J., Kay A.B., Corrigan C.J. The topical glucocorticoids beclomethasone dipropionate and fluticasone propionate inhibit human T-cell allergen-induced production of IL-5, IL-3 and GM-CSF mRNA and protein. Clin Exp Allergy 2001, 31:69-76.
11. Peek E.J., Richards D.F., Faith A., Lavender P., Lee T.H., Corrigan C.J., et al. Interleukin-10-secreting " regulatory" T cells induced by glucocorticoids and beta2-agonists. Am J Respir Cell Mol Biol 2005, 33:105-111.
12. Crocker I.C., Church M.K., Newton S., Townley R.G. Glucocorticoids inhibit proliferation and interleukin-4 and interleukin-5 secretion by aeroallergen-specific T-helper type 2 cell lines. Ann Allergy Asthma Immunol 1998, 80:509-516.
13. Global strategy for asthma management and prevention, updated 2009. Available on the GINA website: http://www.ginasthma.org/.
14. Rossi G.A., Cerasoli F., Cazzola M. Safety of inhaled corticosteroids: room for improvement. Pulm Pharmacol Ther 2007, 20:23-35.
15. Nave R. Clinical pharmacokinetic and pharmacodynamic profile of inhaled ciclesonide. Clin Pharmacokinet 2009, 48:243-252.
16. Silvestri M., Serpero L., Petecchia L., Sabatini F., Cerasoli F., Rossi G.A. Cytokine-activated bronchial epithelial cell pro-inflammatory functions are effectively downregulated in vitro by ciclesonide. Pulm Pharmacol Ther 2006, 19:210-217.
17. Boero S., Sabatini F., Silvestri M., Petecchia L., Nachira A., Pezzolo A., et al. Modulation of human lung fibroblast functions by ciclesonide: evidence for its conversion into the active metabolite desisobutyryl-ciclesonide. Immunol Lett 2007, 112:39-46.
18. 2-adrenoreceptor stimulation but not in cell apoptosis. J Asthma 2000, 37:281-290.
19. Prigione I., Facchetti P., Ghiotto F., Tasso P., Pistoia V. Toxoplasma gondii-specific CD4+ T-cell clones from healthy, latently infected humans display a Th0 profile of cytokine secretion. Eur J Immunol 1995, 25:1298-1305.
20. Nonaka T., Nave R., McCracken N., Kawashimo A., Katsuura Y. Ciclesonide uptake and metabolism in human alveolar type II epithelial cells (A549). BMC Pharmacol 2007, 7:12.
21. Mutch E., Nave R., McCracken N., Zech K., Williams F.M. The role of esterases in the metabolism of ciclesonide to desisobutyryl-ciclesonide in human tissue. Biochem Pharmacol 2007, 73:1657-1664.
22. Lund-Pero M., Jeppson B., Arneklo-Nobin B., Sjögren H.O., Holmgren K., Pero R.W. Non-specific steroidal esterase activity and distribution in human and other mammalian tissues. Clin Chim Acta 1994, 224:9-20.
23. Stoeck M., Riedel R., Hochhaus G., Hafner D., Masso J.M., Schmidt B., et al. In vitro and in vivo anti-inflammatory activity of the new glucocorticoid ciclesonide. J Pharmacol Exp Ther 2004, 309:249-258.
24. Goleva E., Li L.B., Eves P.T., Strand M.J., Martin R.J., Leung D.Y. Increased glucocorticoid receptor beta alters steroid response in glucocorticoid insensitive asthma. Am J Respir Crit Care Med 2005, 173:607-616.
25. Satoh T., Hosokawa M. Structure, function and regulation of carboxylesterases. Chem Biol Interact 2006, 162:195-211.
26. Nave R., Fisher R., Zech K. In vitro metabolism of ciclesonide in human lung and liver precision-cut tissue slices. Biopharm Drug Dispos 2006, 27:197-207.
27. Nave R., McCracken N. Metabolism of ciclesonide in the upper and lower airways, review of available data. J Asthma Allergy 2008, 1:1-18.
28. Haczku A., Alexander A., Brown P., Assoufi B., Li B., Kay A.B., et al. The effect of dexamethasone, cyclosporine, and rapamycin on T-lymphocyte proliferation in vitro: comparison of cells from patients with glucocorticoid-sensitive and glucocorticoid-resistant chronic asthma. J Allergy Clin Immunol 1994, 93:510-519.
29. Walker K.B., Potter J.M., House A.K. Interleukin 2 synthesis in the presence of steroids: a model of steroid resistance. Clin Exp Immunol 1987, 68:162-167.
30. Goleva E., Li L.B., Leung D.Y. IFN-gamma reverses IL-2- and IL-4-mediated T-cell steroid resistance. Am J Respir Cell Mol Biol 2009, 40:223-230.
31. Irusen E., Matthews J.G., Takahashi A., Barnes P.J., Chung K.F., Adcock I.M. p38 Mitogen-activated protein kinase-induced glucocorticoid receptor phosphorylation reduces its activity: role in steroid-insensitive asthma. J Allergy Clin Immunol 2002, 109:649-657.
32. Ito K., Mercado N. Therapeutic targets for new therapy for corticosteroid refractory asthma. Expert Opin Ther Targets 2009, 13:1053-1067.
33. Creed T.J., Lee R.W., Newcomb P.V., di Mambro A.J., Raju M., Dayan C.M. The effects of cytokines on suppression of lymphocyte proliferation by dexamethasone. J Immunol 2009, 183:164-171.
34. Djukanović R., Feather I., Gratziou C., Walls A., Peroni D., Bradding P., et al. Effect of natural allergen exposure during the grass pollen season on airways inflammatory cells and asthma symptoms. Thorax 1996, 51:575-581.
35. Nave R., Watz H., Hoffmann H., Boss H., Magnussen H. Deposition and metabolism of inhaled ciclesonide in the human lung. Eur Respir J 2010, 36:1113-1119.